ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
241.55
+3.43 (1.44%)
Nov 20, 2024, 4:00 PM EST - Market closed

ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of $35.45 billion. The enterprise value is $35.85 billion.

Market Cap 35.45B
Enterprise Value 35.85B

Important Dates

The last earnings date was Thursday, October 24, 2024, after market close.

Earnings Date Oct 24, 2024
Ex-Dividend Date Nov 7, 2024

Share Statistics

ResMed has 146.75 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class 146.75M
Shares Outstanding 146.75M
Shares Change (YoY) +0.02%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 0.53%
Owned by Institutions (%) 73.72%
Float 145.81M

Valuation Ratios

The trailing PE ratio is 32.04 and the forward PE ratio is 25.22. ResMed's PEG ratio is 1.59.

PE Ratio 32.04
Forward PE 25.22
PS Ratio 7.38
Forward PS n/a
PB Ratio 6.82
P/TBV Ratio 19.37
P/FCF Ratio 26.19
P/OCF Ratio 24.61
PEG Ratio 1.59
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.97, with an EV/FCF ratio of 26.50.

EV / Earnings 32.22
EV / Sales 7.46
EV / EBITDA 21.97
EV / EBIT 24.19
EV / FCF 26.50

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.16.

Current Ratio 2.92
Quick Ratio 1.44
Debt / Equity 0.16
Debt / EBITDA 0.51
Debt / FCF 0.63
Interest Coverage 40.98

Financial Efficiency

Return on equity (ROE) is 23.56% and return on invested capital (ROIC) is 15.72%.

Return on Equity (ROE) 23.56%
Return on Assets (ROA) 13.27%
Return on Capital (ROIC) 15.72%
Revenue Per Employee $481,712
Profits Per Employee $111,511
Employee Count 9,980
Asset Turnover 0.69
Inventory Turnover 1.82

Taxes

In the past 12 months, ResMed has paid $263.22 million in taxes.

Income Tax 263.22M
Effective Tax Rate 19.13%

Stock Price Statistics

The stock price has increased by +62.18% in the last 52 weeks. The beta is 0.69, so ResMed's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change +62.18%
50-Day Moving Average 242.11
200-Day Moving Average 213.51
Relative Strength Index (RSI) 50.05
Average Volume (20 Days) 1,185,577

Short Selling Information

The latest short interest is 7.89 million, so 5.38% of the outstanding shares have been sold short.

Short Interest 7.89M
Short Previous Month 8.57M
Short % of Shares Out 5.38%
Short % of Float 5.41%
Short Ratio (days to cover) 7.18

Income Statement

In the last 12 months, ResMed had revenue of $4.81 billion and earned $1.11 billion in profits. Earnings per share was $7.54.

Revenue 4.81B
Gross Profit 2.80B
Operating Income 1.48B
Pretax Income 1.26B
Net Income 1.11B
EBITDA 1.63B
EBIT 1.48B
Earnings Per Share (EPS) $7.54
Full Income Statement

Balance Sheet

The company has $442.58 million in cash and $850.24 million in debt, giving a net cash position of -$407.67 million or -$2.78 per share.

Cash & Cash Equivalents 442.58M
Total Debt 850.24M
Net Cash -407.67M
Net Cash Per Share -$2.78
Equity (Book Value) 5.20B
Book Value Per Share 35.39
Working Capital 1.74B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.44 billion and capital expenditures -$87.27 million, giving a free cash flow of $1.35 billion.

Operating Cash Flow 1.44B
Capital Expenditures -87.27M
Free Cash Flow 1.35B
FCF Per Share $9.22
Full Cash Flow Statement

Margins

Gross margin is 58.33%, with operating and profit margins of 30.84% and 23.15%.

Gross Margin 58.33%
Operating Margin 30.84%
Pretax Margin 28.62%
Profit Margin 23.15%
EBITDA Margin 33.95%
EBIT Margin 30.84%
FCF Margin 27.78%

Dividends & Yields

This stock pays an annual dividend of $2.12, which amounts to a dividend yield of 0.88%.

Dividend Per Share $2.12
Dividend Yield 0.88%
Dividend Growth (YoY) 9.78%
Years of Dividend Growth 12
Payout Ratio 28.12%
Buyback Yield -0.02%
Shareholder Yield 0.85%
Earnings Yield 3.14%
FCF Yield 3.82%
Dividend Details

Analyst Forecast

The average price target for ResMed is $227.63, which is -5.76% lower than the current price. The consensus rating is "Buy".

Price Target $227.63
Price Target Difference -5.76%
Analyst Consensus Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 7.84%
EPS Growth Forecast (5Y) 13.72%
Stock Forecasts

Stock Splits

The last stock split was on August 31, 2010. It was a forward split with a ratio of 2:1.

Last Split Date Aug 31, 2010
Split Type Forward
Split Ratio 2:1

Scores

ResMed has an Altman Z-Score of 10.95 and a Piotroski F-Score of 6.

Altman Z-Score 10.95
Piotroski F-Score 6